Through the global joint reviews, we have already spoken to some of the advantages we see to doing those from the standpoint of allowing our growers to gain access to some of these new chemistries in a similar timeframe. The other very important aspect of this is that because we're working with a number of other OECD countries at the same time, we also have access to each other's science. We have access to each other's risk assessors and scientists, and we're able to make much more robust decisions for all our citizens if we're working together in a larger group assessing these chemicals all at the same time. We gain a lot from that, and I think that adds a lot of confidence into the system regarding these chemicals, their properties, and their safety.
On January 29th, 2008. See this statement in context.